Literature DB >> 26169870

Fatty acid supply with complementary foods and LC-PUFA status in healthy infants: results of a randomised controlled trial.

Lars Libuda1, Christina M Mesch2, Madlen Stimming2, Hans Demmelmair3, Berthold Koletzko3, Petra Warschburger4, Katharina Blanke5, Eva Reischl6, Hermann Kalhoff5, Mathilde Kersting2.   

Abstract

PURPOSE: Introduction of complementary food usually leads to decreasing intakes of long-chain n-3 polyunsaturated fatty acids (n-3 LC-PUFA), compared to full breastfeeding. In the randomised controlled PINGU intervention trial, we tested the effects of complementary foods with different contents of alpha-linolenic acid (ALA) and docosahexaenoic acid (DHA) on term infant LC-PUFA status.
METHODS: Healthy infants born at term were randomised to receive from the introduction of complementary feeding at the age of 4 to 6 months until age of 10 months ready-made complementary meals either with ALA-rich rapeseed oil (intervention group (IG)-R), with salmon twice weekly to provide preformed DHA (IG-F), or with linoleic acid-rich corn oil (control group, CG). Fatty acid composition was assessed in erythrocyte (RBC) and plasma glycerophospholipids.
RESULTS: Complete data of fatty acids in RBC (plasma) were available from 158 (155) infants. After intervention, infants assigned to IG-F showed higher RBC and plasma percentages of eicosapentaenoic acid (EPA), DHA, and total n-3 LC-PUFA than CG (each p < 0.001). In IG-R, levels of ALA and the ratio of ALA to LA in plasma and RBC (all p < 0.0001) as well as RBC-EPA (p < 0.0001) were higher than in CG, while DHA levels did not differ between IG-R and CG.
CONCLUSIONS: Regular fish consumption during complementary feeding enhances infant EPA and DHA status. The usage of rapeseed oil in small amounts concordant with EU-law for commercial meals enhances endogenic EPA-synthesis, but does not affect DHA status. Provision of oily fish with complementary feeds is advisable to prevent a decline of DHA status. CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov , identifier: NCT01487889, title: Polyunsaturated fatty acids in child nutrition-a German multimodal optimisation study (PINGU).

Entities:  

Keywords:  Alpha-linolenic acid; Complementary feeding; Complementary food; DHA; DHA status; Fish; Rapeseed oil

Mesh:

Substances:

Year:  2015        PMID: 26169870     DOI: 10.1007/s00394-015-0982-2

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  36 in total

Review 1.  Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.

Authors:  Carola I F Janssen; Amanda J Kiliaan
Journal:  Prog Lipid Res       Date:  2013-10-24       Impact factor: 16.195

2.  Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants.

Authors:  Camilla T Damsgaard; Lene Schack-Nielsen; Kim F Michaelsen; Maj-Britt Fruekilde; Ole Hels; Lotte Lauritzen
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Food variety in commercial and homemade complementary meals for infants in Germany. Market survey and dietary practice.

Authors:  Christina M Mesch; Madlen Stimming; Kristina Foterek; Annett Hilbig; Ute Alexy; Mathilde Kersting; Lars Libuda
Journal:  Appetite       Date:  2014-02-05       Impact factor: 3.868

Review 5.  Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health.

Authors:  Claudia Glaser; Eva Lattka; Peter Rzehak; Colin Steer; Berthold Koletzko
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

6.  Maturation of visual acuity is accelerated in breast-fed term infants fed baby food containing DHA-enriched egg yolk.

Authors:  Dennis R Hoffman; Richard C Theuer; Yolanda S Castañeda; Dianna H Wheaton; Rain G Bosworth; Anna R O'Connor; Sarah E Morale; Lindsey E Wiedemann; Eileen E Birch
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

7.  PUFA and LC-PUFA intake during the first year of life: can dietary practice achieve a guideline diet?

Authors:  J Schwartz; K Dube; U Alexy; H Kalhoff; M Kersting
Journal:  Eur J Clin Nutr       Date:  2009-11-25       Impact factor: 4.016

8.  The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatidylcholine and phosphatidylethanolamine in human infants.

Authors:  J C Putnam; S E Carlson; P W DeVoe; L A Barness
Journal:  Am J Clin Nutr       Date:  1982-07       Impact factor: 7.045

Review 9.  Role of long-chain polyunsaturated fatty acids in the first year of life.

Authors:  Carlo Agostoni
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

10.  Efficient and specific analysis of red blood cell glycerophospholipid fatty acid composition.

Authors:  Sabrina Klem; Mario Klingler; Hans Demmelmair; Berthold Koletzko
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more
  3 in total

1.  Association between full breastfeeding, timing of complementary food introduction, and iron status in infancy in Germany: results of a secondary analysis of a randomized trial.

Authors:  Lars Libuda; Annett Hilbig; Seda Berber-Al-Tawil; Hermann Kalhoff; Mathilde Kersting
Journal:  Eur J Nutr       Date:  2016-10-24       Impact factor: 5.614

2.  Erythrocyte fatty acid composition of Nepal breast-fed infants.

Authors:  Sigrun Henjum; Øyvind Lie; Manjeswori Ulak; Andrew L Thorne-Lyman; Ram K Chandyo; Prakash S Shrestha; Wafaie W Fawzi; Tor A Strand; Marian Kjellevold
Journal:  Eur J Nutr       Date:  2017-02-25       Impact factor: 5.614

3.  Effects of Malania oleifera Chun Oil on the Improvement of Learning and Memory Function in Mice.

Authors:  Rui Wu; Shaoqi Zhong; Mengmei Ni; Xuejiao Zhu; Yiyi Chen; Xuxi Chen; Lishi Zhang; Jinyao Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-15       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.